Detailed price information for Vir Biotechnology Inc (VIR-Q) from The Globe and Mail including charting and trades.

Get key Q3 2025 insights on Vir Biotechnology’s accelerated hepatitis delta trial milestones, strong financials, and upcoming data catalysts.

First patient enrolled in ECLIPSE 1 Phase 3 clinical trial evaluating combination of tobevibart and elebsiran for chronic suppressive treatment ECLIPSE program designed to enable regulatory ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...

Read full article: What happened in the San Antonio mayor, City Council runoff election on June 7, 2025 Enrique Soriano, 38. Read full article: It’s National Doughnut Day 2025! Here’s where to get ...

BRUSSELS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The Eclipse Foundation, one of the world’s largest open source software foundations, today announced the introduction of the Agent Definition Language (ADL) ...

It addressing this challenge by deploying the second generation blueprint of the Common European Reference Framework  for ...

Join 19 News for extensive coverage of the 2024 Total Solar Eclipse starting on Monday, April 8, with 19 News at Noon. 19 News will be live with LIGHTS OUT IN THE LAND coverage from locations all over ...

If you’re wondering how to watch the solar eclipse that will pass across the mainland United States on August 21, first look to your local library. Last year, when NCIL director Paul Dusenbery and ...

The Eclipse Foundation, best known for its Eclipse IDE, is moving into funding its open source projects via donations. Previously, all Eclipse development was done by individuals and organizations ...

BRUSSELS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The Eclipse Foundation, one of the world’s largest open source software foundations, today announced that Theia AI has been named the winner of the 2025 ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...